Aldermore Group PLC

Prospectus • Sep 29, 2025

National Storage Mechanism | Additional information

RNS Number : 2721B

Aldermore Group PLC

29 September 2025

Aldermore Group PLC

Incorporated in England and Wales

Registration number 06764335

Date: 29 September 2025

Publication of Final Terms

Re:       Final Terms dated 29 September 2025 (the "Final Terms") in relation to Aldermore Group PLC's £300,000,000 6.000 per cent. Fixed Rate Reset Callable Tier 2 Capital Notes due 2035 (ISIN: XS3191631079 (the "Notes") issued under Aldermore Group PLC's £2,000,000,000 Euro Medium Term Note Programme (the "Programme")

Application was made for the Notes to be admitted to the Official List of the Financial Conduct Authority and to trading on the main market of the London Stock Exchange plc with effect from 1 October 2025.

The Final Terms in relation to the Notes are now available for viewing. To view the full document, please paste

the following URL into the address bar of your browser:

https://www.aldermore.co.uk/media/wtspzzmz/final-terms-tier-2-capital-notes.pdf

The Final Terms contain the final terms of the Notes and must be read in conjunction with the base prospectus dated 12 March 2025 relating to the Programme, as supplemented by the base prospectus supplement dated 19 September 2025 (together, the " Prospectus "), which together constitute a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

A copy of the Final Terms has also been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

FURTHER INFORMATION

For further information, please contact:

Joseph Godsmark

Head of Capital Management and Debt Investor Relations

E-mail: [email protected]

Telephone: +44 7789 264250

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms and the Prospectus, including any document incorporated by reference therein, may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom any offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms or the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the " Securities Act ") and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act) except in certain transactions exempt from the registration requirements of the Securities Act.

Neither this announcement nor the Final Terms contain or constitute an offer of securities for sale, or solicitation of an offer to purchase securities, in the United States or any other jurisdiction where such an offer or solicitation would be unlawful. The offering and the distribution of this communication and other information referred to herein may be restricted by law and persons into whose possession this communication and such other information comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PFTEASNNAAXSEFA